Posts Archive for June 2010

Staxyn. Staxyn has been approved by FDA. Staxyn Vardenafil

Jun.23, 2010

United states Food and Drugs Administration approved the medication Staxyn (varbenafil HCL) tablets for the treatment of erectile dysfunction. The main advantage of Staxyn is that tablets are quickly dissolved in the mouth cavity under the tongue. Staxyn is made by GlaxoSmithKline and Merck & Co. The medication will be very soon available on US pharmaceutical market.

Jalyn. FDA approved the drug Jalyn made by Glaxo Smith Klein.

Jun.22, 2010

On June 14, 2010 Food and Drug Administration USA (FDA) approved drug Jalyn (dutasteride 0.5 mg and tamsulosin 0.4 mg) for the treatment of benign prostatic hyperplasia (BPH) in men with prostate enlargement.
Dutasteride is an inhibitor of 5α-reductase, tamsulosin is α1-adrenoceptor blocker. The combination

of dutasteride and tamsulosin has been properly studied in patients with BPH and it was shown high effectiveness and safety profile.

Green tea may slow the progression of chronic lymphocytic leukemia

Jun.17, 2010

The substance contained in green tea may become another tool for the treatment of patients with chronic lymphocytic leukemia (CLL). Researchers from the Mayo Clinic conduct the second phase of study of substance called epigallocatechin gallate (EGCG), also known as Epigallocatechin 3-gallate.

Prolia (denosumab). Prolia has been approved by FDA

Jun.14, 2010

US Food and Drug Administration approved the drug Prolia (denosumab) for the treatment of osteoporosis in postmenopausal women at high risk of fractures as well as for the treatment of bone tissue loss in men, prostate cancer patients with similar risk.

Clinical studies have shown that Denosumab works by improving bone mineral density and reducing different types of fractures.